Related Experiment Video
Updated: Jun 23, 2025

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
Colorectal cancer
Cathy Eng1, Takayuki Yoshino2, Erika Ruíz-García3
1Division of Hematology and Oncology, Vanderbilt University Medical Center, Vanderbilt-Ingram Cancer Center, Nashville, TN, USA.
Colorectal cancer incidence is rising globally, especially in younger patients. Advances in systemic therapy, surgery, and targeted treatments are improving survival rates for this common cancer.
Area of Science:
- Oncology
- Gastroenterology
- Surgical Oncology
Background:
- Colorectal cancer remains a leading global cancer diagnosis, with rising incidence in emerging economies and increasing concern for early-onset cases (age ≤50 years).
- Despite decreasing rates in some high-income populations, the overall global burden necessitates continued research and clinical advancements.
Purpose of the Study:
- To provide a multidisciplinary overview of recent clinical advances in the management of colorectal cancer.
- To highlight key areas of ongoing research and future directions in colorectal cancer treatment.
Main Methods:
- This overview synthesizes current clinical research and expert perspectives on colorectal cancer management.
- It examines advances in systemic therapy, surgical techniques, and molecularly targeted treatments.
Main Results:
- Significant progress has been made in increasing overall survival rates through improved systemic therapies and surgical options.
- Ongoing research focuses on sphincter preservation, precision oncology, circulating tumor DNA, microbiome analysis, and liver metastases management.
Conclusions:
- Multidisciplinary approaches and ongoing research are crucial for improving outcomes in colorectal cancer.
- Future directions emphasize personalized medicine and innovative locoregional strategies to combat this disease.
Related Concept Videos
Assessment of the Rectum and Anus
Rectal Inspection
Begin by inspecting the perianal and anal areas for color, texture, rashes,...
Cancer Prevention
Some...
Endoscopic Procedures II: Colonoscopy
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...

